Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin therapy: a retrospective observational study.

Although Model 2 exhibited a higher AUC than Model 1, this increase did not reach statistical significance ( P = 0.302).

also in 111,027 other papers

Significantly, in the comprehensive Model 3, which controlled for both time points, day 8 lymphocyte and monocyte counts remained highly significant independent predictors of treatment suspension, alongside pre-treatment neutrophil counts.

also in 132,142 other papers